GE HealthCare Technologies Inc. (GEHC)
GE HealthCare Technologies Inc. (GEHC) carries a ŷRobot AI score of 45 out of 100. The model's fair value estimate is $64.05, 7.9% below the last close of $69.57. The chart signal reads Hold.
| Metric | GEHC |
|---|---|
| AI score | 45 / 100 |
| Chart signal | Hold |
| Fair value estimate | $64.05 |
| Upside to fair value | -7.9% |
| Previous close | $69.57 |
| P/E | 15.31 |
| Price / sales | 1.36 |
| Market cap | $31.15B |
| EPS | 4.34 |
| Revenue growth | 3.6% |
| 1-year price change | 2.2% |
How these numbers are built: the AI score, the fair value model, and the chart signal.
Other Healthcare stocks: Eli Lilly and Company, Johnson & Johnson, AbbVie Inc, UnitedHealth Group Incorporated, Merck & Company Inc, Novartis AG ADR.
Questions about GEHC
Is GEHC overvalued or undervalued right now?
As of Oct 16, 2026, ŷRobot's fair-value model estimates GE HealthCare Technologies Inc. (GEHC) at $64.05 against a last close of $69.57, implying 7.9% downside to the model's estimate.
Is GEHC's chart signal bullish or bearish?
The chart-signal model classifies GEHC as Neutral as of Oct 16, 2026, with a signal score of 0.03 on a -1 to 1 scale.
What is GEHC's ŷRobot AI score?
GEHC scores 45 out of 100 on ŷRobot's AI composite, which measures how strongly the fair-value and chart models agree, as of Oct 16, 2026.
Is GEHC stock expensive on P/E and P/S?
GEHC trades at 15.3 times earnings and 1.4 times sales as of Oct 16, 2026.
What does GEHC's seasonal forecast show?
ŷRobot's seasonal forecast curve for GEHC reads +1.0% at 30 days, +1.4% at 90 days, and +2.2% at one year as of Oct 16, 2026. Seasonal tendencies are historical patterns, not predictions.
How fast is GEHC growing?
GE HealthCare Technologies Inc.'s revenue growth is +3.6% and free-cash-flow growth is -2.3% on the latest reported figures.
GEHC chart and technical read · All covered stocks
ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.